down arrow

Coral Labs.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE683E01017
  • NSEID:
  • BSEID: 524506
INR
647.00
-23 (-3.43%)
BSENSE

Apr 11, 12:50 PM

BSE+NSE Vol: 1.4 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

1.4 k (138.28%) Volume

Shareholding (Sep 2024)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

71.51%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor Management Efficiency with a low ROE of 6.89%

  • The company has been able to generate a Return on Equity (avg) of 6.89% signifying low profitability per unit of shareholders funds
2

Company has a low Debt to Equity ratio (avg) at 0 times

 
3

Healthy long term growth as Operating profit has grown by an annual rate 96.24%

 
4

With a growth in Net Profit of 184.26%, the company declared Very Positive results in Dec 24

5

Stock is technically in a Bearish range

6

With ROE of 15.3, it has a Very Attractive valuation with a 1.3 Price to Book Value

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 231 Cr (Micro Cap)

stock-summary
P/E

9.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.30%

stock-summary
Debt Equity

-0.49

stock-summary
Return on Equity

15.31%

stock-summary
Price to Book

1.35

Revenue and Profits (1 Year):
Net Sales:
23 Cr
(Quarterly Results - Dec 2024)
Net Profit:
6 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.3%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-26.14%
0%
-26.14%
1 Year
69.28%
0.53%
69.81%
2 Years
153.73%
0.77%
154.5%
3 Years
129.8%
0.82%
130.62%
4 Years
83.75%
0.49%
84.24%
5 Years
362.31%
1.25%
363.56%

Latest dividend: 2 per share ex-dividend date: Sep-20-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
10.80%
EBIT Growth (5y)
96.24%
EBIT to Interest (avg)
11.96
Debt to EBITDA (avg)
0.51
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.58
Tax Ratio
25.45%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.86%
ROE (avg)
6.89%
Valuation key factors
Factor
Value
P/E Ratio
9
Industry P/E
33
Price to Book Value
1.35
EV to EBIT
5.48
EV to EBITDA
5.11
EV to Capital Employed
1.68
EV to Sales
1.32
PEG Ratio
0.04
Dividend Yield
0.30%
ROCE (Latest)
15.78%
ROE (Latest)
15.31%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Chetan Navinchandra Doshi (51.54%)

Highest Public shareholder

Meeta Samir Sheth (1.84%)

Individual Investors Holdings

21.18%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 27.16% vs -26.89% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 184.26% vs 151.16% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "22.99",
          "val2": "18.08",
          "chgp": "27.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "6.31",
          "val2": "2.10",
          "chgp": "200.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.02",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.07",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "6.14",
          "val2": "2.16",
          "chgp": "184.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "27.45%",
          "val2": "11.62%",
          "chgp": "15.83%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 74.06% vs -12.51% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 93.38% vs 21.14% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "63.88",
          "val2": "36.70",
          "chgp": "74.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "17.23",
          "val2": "7.89",
          "chgp": "118.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.04",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "15.18",
          "val2": "7.85",
          "chgp": "93.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.97%",
          "val2": "21.50%",
          "chgp": "5.47%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 58.58% vs -17.85% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 112.99% vs 36.38% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "86.87",
          "val2": "54.78",
          "chgp": "58.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "23.54",
          "val2": "9.99",
          "chgp": "135.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.06",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.07",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "21.32",
          "val2": "10.01",
          "chgp": "112.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "27.10%",
          "val2": "18.24%",
          "chgp": "8.86%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 7.09% vs 3.32% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 144.81% vs -28.73% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "83.66",
          "val2": "78.12",
          "chgp": "7.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "16.24",
          "val2": "3.81",
          "chgp": "326.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.34",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.16",
          "val2": "0.04",
          "chgp": "-500.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "15.79",
          "val2": "6.45",
          "chgp": "144.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "19.41%",
          "val2": "4.88%",
          "chgp": "14.53%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
22.99
18.08
27.16%
Operating Profit (PBDIT) excl Other Income
6.31
2.10
200.48%
Interest
0.02
0.00
Exceptional Items
0.00
-0.07
100.00%
Standalone Net Profit
6.14
2.16
184.26%
Operating Profit Margin (Excl OI)
27.45%
11.62%
15.83%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 27.16% vs -26.89% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in quarter ended Dec 2024 is 184.26% vs 151.16% in Dec 2023

Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
63.88
36.70
74.06%
Operating Profit (PBDIT) excl Other Income
17.23
7.89
118.38%
Interest
0.04
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
15.18
7.85
93.38%
Operating Profit Margin (Excl OI)
26.97%
21.50%
5.47%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 74.06% vs -12.51% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is 93.38% vs 21.14% in Sep 2023

Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
86.87
54.78
58.58%
Operating Profit (PBDIT) excl Other Income
23.54
9.99
135.64%
Interest
0.06
0.00
Exceptional Items
0.00
-0.07
100.00%
Standalone Net Profit
21.32
10.01
112.99%
Operating Profit Margin (Excl OI)
27.10%
18.24%
8.86%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 58.58% vs -17.85% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 112.99% vs 36.38% in Dec 2023

Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
83.66
78.12
7.09%
Operating Profit (PBDIT) excl Other Income
16.24
3.81
326.25%
Interest
0.00
0.34
-100.00%
Exceptional Items
-0.16
0.04
-500.00%
Standalone Net Profit
15.79
6.45
144.81%
Operating Profit Margin (Excl OI)
19.41%
4.88%
14.53%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 7.09% vs 3.32% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is 144.81% vs -28.73% in Mar 2023

stock-summaryCompany CV
About Coral Laboratories Ltd stock-summary
stock-summary
Coral Laboratories Ltd
Micro Cap
Pharmaceuticals & Drugs
Coral Laboratories Limited (CLL) was established in February, 1997. Carol Labs are into manufacturing of Generic Branded, Nutraceuticals, OTC and Herbal Medicines. The Company produces various pharmaceutical formulations in 3 different locations all over India. It has plants at Daman and Dehradun . The Company was promoted by Navin B Doshi of the DWD group.
Company Coordinates stock-summary
Company Details
SF-206 Silver Oak Complex, BPC Road Vadodara Gujarat : 390020
stock-summary
Tel: 91-022-2500 5245/46
stock-summary
cs@corallab.com
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai